International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Europe Virtual Masterclass

Course Overview

The IPC Virtual Psoriasis Masterclass is designed for early career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.

Over the five weekly two hours of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.

The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.

The IPC Masterclass is open to dermatologists who meet the following criteria:

  • A diploma, 1st part MSc or higher degree in internal medicine or dermatology
  • Practicing internal medicine or dermatology within a governmental establishment i.e. university hospital, public hospitals, rural hospitals, etc.
  • At least 3 years of dermatology practice
  • General practitioners or dermatologists interested in psoriasis and who see at least two cases of psoriasis per week

All sessions of the IPC Virtual Psoriasis Masterclass are accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s)* (2 credits per session). For more details, please see the EACCME Accreditation Letters for session 1, session 2, session 3, session 4, and session 5.

There is no cost to attend the program, but space is limited. The application deadline is May 15, 2023.

Timezones:
12:00-14:00 BST
13:00-15:00 CEST
14:00-16:00 EEST

Agendas

Psoriasis: The Problem


WELCOME + INTRODUCTION

Psoriasis Epidemiology: What Do We Know?
Darren Ashcroft

Genetic and Environmental Determinants of Disease: Relevance to Clinical Practice
Lluis Puig

Clinical Phenotypes
Chris Griffiths

Psoriasis Multi-morbidity & Mechanisms
Johann Gudjonsson

CLOSING COMMENTS

Comprehensive Patient-Centered Care


WELCOME + INTRODUCTION

Psoriasis: Assessment of Disease Severity in Clinical Practice
Lone Skov

Psoriatic Arthritis: Making the Diagnosis
Laura Coates

Cardiometabolic Disease: How and When to Assess
Joel Gelfand

Understanding Patient Goals
Chris Bundy

Panel Q & A

CLOSING COMMENTS

Management Approaches


WELCOME + INTRODUCTION

Lifestyle & Diet: What Do We Know
Jo Lambert

Topicals: When and How to Use
Robert Bissonnette

Phototherapy: Does it Still Have a Role?
Colby Evans

The Importance of Standard Systemics in Routine Care
Phyllis Spuls

Targeted Therapies: Where are the Differences
Luigi Naldi

CLOSING COMMENTS

Medicines Management


WELCOME + INTRODUCTION

Principles of Safe & Effective Prescribing
Satveer Mahil

Precision Medicine & Predictors of Success
Catherine Smith

Therapeutic Drug Monitoring
Jo Lambert

Psoriasis and Conception, Pregnancy and Breast Feeding
Richard Woolf

Psoriasis and Cancer
Ron Vender

CLOSING COMMENTS

Challenging Case Presentation + Expert Discussion


WELCOME + INTRODUCTION

Clinic Organization: Getting It All Done
Jo Lambert

Challenging Cases
Severe Paradoxical Psoriasis with Comorbidities
Albert Duvetorp

Psoriasis and Mental Health
Juul van den Reek

Challenging Psoriasis Cases Workshop – presented by Delegates

PROGRAM CLOSING

Program Co-Chairs

Jo Lambert, MD, PhD

Ghent University Hospital

Ghent, Belgium

Bio

Catherine Smith, MD

St John’s Institute of Dermatology, Guys and St Thomas’ Hospitals

London, United Kingdom

IPC Board Member

Bio

Program Faculty

Darren Ashcroft, BPharm, MSc, PhD, MRPharmS

University of Manchester

Manchester, United Kingdom

Bio

Robert Bissonnette, MD

Innovaderm

Montreal, Quebec, Canada

Bio

Christine Bundy, PhD, AFBPS, C Psychol

University of Cardiff

Cardiff, United Kingdom

Bio

Laura Coates, MBChB, PhD

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford

Oxford, United Kingdom

Bio

Albert Duvetorp, MD, PhD

Skåne University Hospital

Malmö, Sweden

Bio

Colby Evans, MD

Evans Dermatology Partners

Austin, Texas, United States

Bio

Joel Gelfand, MD, MSCE

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Treasurer

Bio

Christopher Griffiths, OBE, MD, FRCP, FMedSci

University of Manchester

Manchester, United Kingdom

Honorary Founder

Bio

Johann Gudjonsson, MD, PhD

University of Michigan, Department of Dermatology

Ann Arbor, Michigan, United States

IPC Board Member

Bio

Satveer Mahil, PhD, MRCP

St John’s Institute of Dermatology

London, United Kingdom

Bio

Luigi Naldi, MD

Centro Studi GISED, Bergamo

Vicenza and Bergamo, Italy

Bio

Lluís Puig, MD, PhD

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Board Member

Bio

Lone Skov, MD, PhD

Herlev and Gentofte Hospital, University of Copenhagen

Hellerup, Denmark

IPC Board Member

Bio

Phyllis Spuls, MD, PhD

Amsterdam Public Health/Infection and Immunology

Amsterdam, Netherlands

Bio

Juul van den Reek, MD, PhD

Radboud University Medical Center

Nijmegen, Netherlands

Bio

Ronald Vender, MD, FRCPC

Dermatrials Research, INC.

Hamilton, Ontario, Canada

Bio

Richard Woolf, MBChB, PhD, MRCP

St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust

London, United Kingdom

Bio